CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction Management of ST-segment elevation myocardial infarction in predominantly rural central China: A retrospective observational study Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

Consensus27 May 2020

JOURNAL:JACC: Cardiovascular Interventions Article Link

Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group

RV Jeger, S Eccleshall et al for the International DCB Consensus Group Keywords: DCB; de novo small-vessel disease; high bleeding risk; bifurcation lesions, large-vessel disease; diabetes mellitus; ACS

Full Text PDF